13-year-old Alyssa was suffering from a condition of leukemia that medicines do not affect, but now it has been six months and she is safe from cancer. Photo: File
London: British doctors have tested for the first time a brand new therapy on a girl suffering from a particular type of leukemia, which has achieved extraordinary success.
Alyssa, a 13-year-old girl, was diagnosed with T-cell acute lymphoblastic leukemia in 2021, which underwent chemotherapy and bone marrow transplantation, including conventional treatments.
London’s Great Armand Street Hospital for Children (GOSH) has inserted genetically engineering amniotic cells taken from a healthy human being. After just 28 days, his cancer decreased, after which he was transferred to Bon Mir to strengthen this natural defense system. Now, six months later, she is still in good health and lives in her home. Sometimes Elsa has to be brought to the hospital for a routine check-up.
It was an experimental treatment that required permission from Alyssa’s parents, but experts around the world have described it as a ‘revolutionary treatment’. However, the patient will be monitored for several more months. Although acute lymphoblastic leukemia (ALL) is common in children that fails immune cells, no medication was affecting ELISA and that is why it was subjected to new treatments.
ELISA is the first patient to have been implanted with altered T cells that go into the body and make specific proteins under special instructions. In this way, T cells attack the cancer cells and there is no harm to the surrounding healthy cells.
According to scientists, the world’s best cell technology has been used in this treatment, but ELISA will now be under the observation of doctors for several months.